Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum. AMRX has gained 69% over the past year. Shares maintain a 100% “Buy” technical opinion on Barchart. Analyst sentiment is positive, with multiple “Strong Buy” ratings and price targets as high as $15. Today’s Featured Stock Valued at$3.98 billion, Amneal Pharmaceuticals (AMRX) is an integrated specialty pharmaceutical company. It focuses on developing, manufacturing, and distributing generic, brand, and ...